GLTO Galecto Inc
Price (delayed)
$13.81
Market cap
$14.99M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$23.25
Enterprise value
-$7.88M
Galecto is a clinical stage biotechnology company committed to the development of novel small molecule therapeutics directed at biological targets which are at the heart of fibrosis, inflammation, and cancer.
Highlights
Galecto's debt has plunged by 100% YoY
GLTO's EPS has surged by 54% year-on-year and by 18% since the previous quarter
The quick ratio has soared by 76% YoY but it has contracted by 2.1% from the previous quarter
GLTO's equity is down by 46% year-on-year and by 16% since the previous quarter
Key stats
What are the main financial stats of GLTO
Market
Valuations
Earnings
Shares outstanding
1.09M
Market cap
$14.99M
Enterprise value
-$7.88M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.63
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$25.38M
EBITDA
-$24.61M
Free cash flow
-$29.88M
Per share
Balance sheet
Liquidity
EPS
-$23.25
Free cash flow per share
-$27.55
Book value per share
$21.75
Revenue per share
$0
TBVPS
$25.17
Total assets
$27.3M
Total liabilities
$3.71M
Debt
$0
Equity
$23.59M
Working capital
$21.46M
Debt to equity
0
Current ratio
6.79
Quick ratio
6.16
Net debt/EBITDA
0.93
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-68.7%
Return on equity
-83.7%
Return on invested capital
-304.7%
Return on capital employed
-107.6%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
GLTO stock price
How has the Galecto stock price performed over time
Intraday
-1.99%
1 week
5.26%
1 month
-4.82%
1 year
-6.37%
YTD
-23.28%
QTD
16.44%
Financial performance
How have Galecto's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$26.57M
Net income
-$25.43M
Gross margin
N/A
Net margin
N/A
GLTO's net income has surged by 51% year-on-year and by 18% since the previous quarter
The company's operating income rose by 49% YoY and by 17% QoQ
Growth
What is Galecto's growth rate over time
Valuation
What is Galecto stock price valuation
P/E
N/A
P/B
0.63
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
GLTO's EPS has surged by 54% year-on-year and by 18% since the previous quarter
GLTO's equity is down by 46% year-on-year and by 16% since the previous quarter
GLTO's price to book (P/B) is 8% more than its last 4 quarters average of 0.6
Efficiency
How efficient is Galecto business performance
The company's return on invested capital has shrunk by 80% YoY and by 33% QoQ
The return on assets has increased by 7% year-on-year
Galecto's ROE has increased by 7% YoY and by 3.9% from the previous quarter
Dividends
What is GLTO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for GLTO.
Financial health
How did Galecto financials performed over time
The current ratio has soared by 83% YoY but it fell by 4% QoQ
The quick ratio has soared by 76% YoY but it has contracted by 2.1% from the previous quarter
Galecto's debt is 100% less than its equity
Galecto's debt has plunged by 100% YoY
GLTO's equity is down by 46% year-on-year and by 16% since the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.